Research and News Involving:
AI Validation



Treating an Ultra-Rare Pediatric Disease (CLIFAHDD) with an Anti-Nausea Drug

Treating an Ultra-Rare Pediatric Disease (CLIFAHDD) with an Anti-Nausea Drug ​Principal Investigator: Drs Jeremy Tanner and Megan Iammarino Disease: Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay Research Description: Congenital...





Press Release: Cures Within Reach Selected Three Clinical Trials in Rare/Ultra-Rare Diseases to Validate AI Predictions

Press Release: Cures Within Reach Selected Three Clinical Trials in Rare/Ultra-Rare Diseases to Validate AI Predictions Cures Within Reach Selected Three Clinical Trials in Rare/Ultra-Rare Diseases to Validate AI Predictions These clinical trials highlight...

Press Release: Cures Within Reach Opens Call to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches

Press Release: Cures Within Reach Opens Call to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches Cures Within Reach Opens Call to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches Trials have the potential...

Press Release: Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches

Press Release: Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate AI-Generated Drug-Disease Repurposing Matches Cures Within Reach Receives Grant from Chan Zuckerberg Initiative to Fund Clinical Trials that Validate...